QR-kod

Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand.

Combined treatment with allogeneic small lymphocytes or T-depleted small lymphocytes plus a blocking antibody to CD40 ligand (CD40L) permitted indefinite pancreatic islet allograft survival in 37 of 40 recipients that differed from islet donors at major and minor histocompatibility loci. The effect...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Proc Natl Acad Sci U S A
Huvudupphov: Parker, D C, Greiner, D L, Phillips, N E, Appel, M C, Steele, A W, Durie, F H, Noelle, R J, Mordes, J P, Rossini, A A
Materialtyp: Artigo
Språk:Inglês
Utgiven: National Academy of Sciences 1995
Ämnen:
Länkar:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC40841/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7568172/
https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.92.21.9560
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!